Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.24.0.1
SHARE-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2023
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION
NOTE 12: -
SHARE-BASED COMPENSATION
 
  a.
Share incentive plans:
 
In 2016, the Company’s Board of Directors adopted an Employee Shares Incentive Plan (the “2016 Plan”). Under the 2016 Plan, options may be granted to employees, officers, consultants and directors of the Company and its subsidiaries.
 
The 2016 plan was terminated in 2021, although option awards outstanding as of that date will continue in full force in accordance with the terms under which they were granted.
 
In 2021, the Company’s Board of Directors adopted a new Share Incentive Plan (the “2021 Plan”). According to the 2021 Plan, share awards, options to purchase shares or Restricted Share Units (RSUs) may be granted to employees, directors, consultants and other service providers of the Company or any affiliate of the Company.
 
Under the 2021 Plan, as of December 31, 2023, a total of 247,819 shares were still available for future grant. Each option granted under the 2021 Plan expires no later than seven years from the date of grant. The options vest primarily over four years of employment unless the Board of Directors and the Board of Director’s Compensation Committee determines otherwise. Any option which is forfeited or cancelled before expiration becomes available for future grants.
 
  b.
Options granted:
 
The fair value of the Company’s share options granted for the years ended December 31, 2023, 2022 and 2021, was estimated using the following weighted average assumptions:
 
   
Year ended December 31,
  
   
2023
    
2022
    
2021
  
                   
Expected term, in years
    
4.59
      
4.61
    
4.40
  
Expected volatility
    
67%
      
66%
    
64%
  
Risk-Free interest rate
    
4.30%-4.55%
      
1.54%-4.36%
    
0.48%-1.01%
  
Expected dividend yield
    
0%
      
0%
 
  
0%
  
 
A summary of option balances as of December 31, 2023, and changes during the year then ended are as follows:
 
   
Number of options
    
Weighted-average exercise price
    
Weighted- average remaining contractual term
(in years)
    
Aggregate intrinsic value
  
                         
Outstanding at January 1, 2023
    
14,080,996
    
$
5.24
      
6.00
    
$
19,724
  
                                 
Granted
    
474,344
    
$
3.95
                  
Exercised
    
631,970
    
$
0.72
            
$
1,444
  
Forfeited
    
396,135
    
$
5.41
                  
Expired
    
197,799
    
$
7.38
                  
                                 
Outstanding at December 31, 2023
    
13,329,436
    
$
5.38
      
5.07
    
$
9,584
  
                                 
Exercisable at December 31, 2023
    
10,580,281
    
$
5.35
      
4.97
    
$
8,954
  
 
The weighted-average grant date fair value of options granted during the years ended December 31, 2023, 2022 and 2021, was $2.26, $2.35 and $4.75, respectively.
 
Exercise price - before the Company became public in April 2021, in determining the exercise prices for share options granted, the Board of Directors considered the fair value of Ordinary Shares as of each grant date. The fair value of Ordinary Shares underlying the share options was determined by the Board of Directors at each award grant date based upon a variety of factors, including the results obtained from independent third-party valuations, the Company’s financial position and historical financial performance, the status of technological developments within the Company’s products, the composition and ability of the current management team, an evaluation or benchmark of the Company’s competition, the current business climate in the marketplace, the illiquid nature of the Ordinary Shares, arm’s length sales of the Company’s capital share, the effect of the rights and preferences of the Preferred Shares, and the prospects of a liquidity event, among others. From the date the Company became public, the fair value of each Ordinary Share was based on the closing price of the Company’s publicly traded Ordinary Shares as reported on the date of the grant.
 
Expected volatility - as the Company became public in April 2021, there is not sufficient historical volatility for the expected term of the share options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly traded companies which were selected based upon industry similarities.
 
Expected term (years) - represents the period that the Company’s options granted are expected to be outstanding. There is not sufficient historical share exercise data to calculate the expected term of the share options. Therefore, the Company elected to utilize the simplified method to value option grants. Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting term and the contractual term of the option.
 
Risk-free interest rate - the Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant.
 
Expected dividend yield - since inception, the Company has not paid and does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.
 
  c.
RSUs granted:
 
A summary of RSUs activity for the year ended December 31, 2023, is as follows:
 
   
Number of
shares
    
Weighted average grant date fair value per share
  
             
Unvested as of December 31, 2022
    
7,308,579
    
$
5.95
  
Granted
    
7,238,480
    
$
3.83
  
Vested
    
2,216,986
    
$
5.78
  
Forfeited
    
630,185
    
$
5.06
  
Unvested as of December 31, 2023
    
11,699,888
    
$
4.72
  
 
  d.
Management earn-out shares:
 
The fair value of the Management earn-out shares granted to officers on May 12, 2021 was estimated using the Monte Carlo pricing model under the following assumptions:
 
   
May 12, 2021
  
       
Share Price
  
$
9.75
  
Expected volatility
    
77.50
%
Risk-Free interest rate
    
0.66
%
Threshold
  
$
12.5
  
Term (years)
    
4
  
 
Share price - the share price was based on the closing price of the share on day of grant.
 
Expected volatility - the Company estimates the volatility of the earn-out shares based on the historical volatility of the company’s share price and of a selected peer companies that matches the expected remaining life of the earn-out shares.
 
Risk-free interest rate - the Company determined the risk-free interest rate by using a weighted average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant.
 
Threshold - the Company determined the earnout share price as part of the Transactions agreement.
 
  e.
The total share-based compensation expense related to all of the Company’s equity-based awards, which include options and RSUs recognized in the Company’s consolidated statements of operations are as follow:
 
   
Year ended December 31,
  
   
2023
    
2022
    
2021
  
                   
Cost of revenues
  
$
1,587
    
$
174
    
$
-
  
Research and development
    
13,690
      
11,995
      
25,504
  
Sales and marketing
    
1,409
      
2,300
      
17,153
  
General and administrative
    
5,634
      
4,980
      
22,079
  
 
                        
   
$
22,320
    
$
19,449
    
$
64,736
  
 
As of December 31, 2023, unrecognized compensation cost related to share options and RSUs was $51,352, which is expected to be recognized over a weighted average period of 2.86 years.
 
  f.
For awards issued for non-employees’ services, see Note 1c.
 
These awards were accounted for as issuance costs in connection with the Transactions.